Jean Michel Saad

Jean Michel Saad

Auto-generated profile, based on publicly available information

Jean Michel Saad

Department of Cardiology, Houston Methodist Hospital , Houston, TX, USA

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 September 2022 in International Journal of Cardiology
Verified
Journal Article
Closed access
AAAhmed Ibrahim Ahmed
Ahmed Ibrahim Ahmed
MRMahmoud Al Rifai
Mahmoud Al Rifai
FAFares Alahdab
Fares Alahdab
JSJean Michel Saad
Jean Michel Saad
YHYushui Han
Yushui Han
MAMouaz H Al-Mallah
Mouaz H Al-Mallah

23 March 2025 in Journal of Nuclear Cardiology
Verified
Journal Article
Closed access
MRMahmoud Al Rifai
Mahmoud Al Rifai
MAMaria Alwan
Maria Alwan
AAAhmed Ibrahim Ahmed
Ahmed Ibrahim Ahmed
FNFaisal Nabi
Faisal Nabi
ASAhmed Soliman
Ahmed Soliman
MAMouaz H Al-Mallah
Mouaz H Al-Mallah

28 October 2021 in Heart Failure Reviews
Verified
Journal Article
Closed access
PDF file
JSJean Michel Saad
Jean Michel Saad
AAAhmed Ibrahim Ahmed
Ahmed Ibrahim Ahmed
YHYushui Han
Yushui Han
SSSubha Saeed
Subha Saeed
PPPayam Pournazari
Payam Pournazari
MAMouaz H Al-Mallah
Mouaz H Al-Mallah

15 December 2021 in Methodist DeBakey Cardiovascular Journal
Verified
Journal Article
Open access
PDF file
Awad JavaidAwad Javaid
Awad Javaid
YSYehia Saleh
Yehia Saleh
AAAhmed Ibrahim Ahmed
Ahmed Ibrahim Ahmed
JSJean Michel Saad
Jean Michel Saad
MMMaan Malahfji
Maan Malahfji
MAMouaz H Al-Mallah
Mouaz H Al-Mallah
Acute chest pain is a common presentation in patients with COVID-19. Although noninvasive cardiac imaging modalities continue to be important cornerstones of management, the pandemic has brought forth difficult and unprecedented challenges in the provision of timely care while ensuring the safety of patients and providers. Clinical practice has adapted to these challenges, with several recommendations and societal guidelines emerging on the appropriate use of imaging modalities. In this review, we summarize the current evidence base on the use of noninvasive cardiac imaging modalities in COVID-19 patients with acute chest pain, with a focus on acute coronary syndromes.

24 June 2024 in Current Atherosclerosis Reports
Verified
Journal Article
Closed access
PDF file
MNMalek Nayfeh
Malek Nayfeh
HDHelene DiGregorio
Helene DiGregorio
JSJean Michel Saad
Jean Michel Saad
MAMouaz H Al-Mallah
Mouaz H Al-Mallah
MRMahmoud Al Rifai
Mahmoud Al Rifai

14 March 2022 in Methodist DeBakey Cardiovascular Journal
Verified
Journal Article
Open access
PDF file
JSJean Michel Saad
Jean Michel Saad
AAAhmed Ibrahim Ahmed
Ahmed Ibrahim Ahmed
DADixitha Anugula
Dixitha Anugula
YHYushui Han
Yushui Han
MAMoath Said Alfawara
Moath Said Alfawara
MAMouaz H Al-Mallah
Mouaz H Al-Mallah
Cardiac amyloidosis (CA) is the buildup and infiltration of amyloid plaque in cardiac muscle. An underdiagnosed form of restrictive cardiomyopathy, CA can rapidly progress into heart failure. CA is evaluated using a multimodality approach that includes echocardiography, cardiac magnetic imaging, and nuclear imaging. Echocardiography remains an essential first-line modality that raises suspicion for CA and establishes functional baselines. Cardiac magnetic imaging provides additional incremental value via high-resolution imaging, robust functional assessment, and superior tissue characterization, all of which enable a more comprehensive investigation of CA. Cardiac scintigraphy has eliminated the need for invasive diagnostic approaches and helps differentiate CA subtypes. Positron emission tomography is the first modality introducing targeted amyloid binding tracers that allow for precise burden quantification, early detection, and disease monitoring. In this review, we highlight the role of several cardiac imaging techniques in the evaluation of CA.